During the past decade, Klinik Kesihatan Seremban 2 conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Klinik Kesihatan Seremban 2" are "COVID-19 Pandemic" (1 trials) and "Influenza" (1 trials). Many other conditions were trialed in "Klinik Kesihatan Seremban 2" in a lesser frequency.

Most popular intervention types in "Klinik Kesihatan Seremban 2" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)" (1 trials), "MF59-adjuvanted Quadrivalent Subunit Inactivated Egg-derived Influenza Vaccine (aQIV)" (1 trials), "Non-Influenza Comparator (Boostrix)" (1 trials) and "Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinik Kesihatan Seremban 2" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Klinik Kesihatan Seremban 2". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klinik Kesihatan Seremban 2, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinik Kesihatan Seremban 2, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".